The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Levoamlodipine Market Research Report 2024

Global Levoamlodipine Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739789

No of Pages : 108

Ask Your Query

Synopsis
Levoamlodipine can effectively control 24-hour blood pressure, especially at night blood pressure control has unique advantages, it can also effectively prevent the sudden rise of blood pressure in the morning, reduce the sharp rise and fall of blood pressure, so as to effectively maintain the blood flow of important organs and protect the function of target organs.

Global Levoamlodipine market is projected to reach US$ 75320 million in 2029, increasing from US$ 35600 million in 2022, with the CAGR of 11.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Levoamlodipine market research.

Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Levoamlodipine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Aristo Pharmaceuticals Pvt Ltd
  • Novartis
  • Pfizer
  • Lek
  • TEVA
  • Macleods Pharmaceuticals
  • Caraco Pharmaceutical
  • Sanis Health
  • Jamp Pharma
  • Accel Pharma
  • Jubilant Generics
  • Angita Pharma
  • Florida DOH Central Pharmacy
  • Chengdu Di'ao Pharmaceutical Group Co., Ltd.
  • Yangzijiang Pharmaceutical

Segment by Type

  • Amlodipine Besylate Tablets
  • Amlodipine Mesylate Tablets
  • Amlodipine Maleate Tablets

Segment by Application

  • Hypertension
  • Angina pectoris

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Levoamlodipine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Levoamlodipine Market Overview
1.1 Product Overview and Scope of Levoamlodipine
1.2 Levoamlodipine Segment by Type
1.2.1 Global Levoamlodipine Market Value Comparison by Type (2023-2029)
1.2.2 Amlodipine Besylate Tablets
1.2.3 Amlodipine Mesylate Tablets
1.2.4 Amlodipine Maleate Tablets
1.3 Levoamlodipine Segment by Application
1.3.1 Global Levoamlodipine Market Value by Application: (2023-2029)
1.3.2 Hypertension
1.3.3 Angina pectoris
1.4 Global Levoamlodipine Market Size Estimates and Forecasts
1.4.1 Global Levoamlodipine Revenue 2018-2029
1.4.2 Global Levoamlodipine Sales 2018-2029
1.4.3 Global Levoamlodipine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Levoamlodipine Market Competition by Manufacturers
2.1 Global Levoamlodipine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Levoamlodipine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Levoamlodipine Average Price by Manufacturers (2018-2023)
2.4 Global Levoamlodipine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Levoamlodipine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Levoamlodipine, Product Type & Application
2.7 Levoamlodipine Market Competitive Situation and Trends
2.7.1 Levoamlodipine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Levoamlodipine Players Market Share by Revenue
2.7.3 Global Levoamlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Levoamlodipine Retrospective Market Scenario by Region
3.1 Global Levoamlodipine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Levoamlodipine Global Levoamlodipine Sales by Region: 2018-2029
3.2.1 Global Levoamlodipine Sales by Region: 2018-2023
3.2.2 Global Levoamlodipine Sales by Region: 2024-2029
3.3 Global Levoamlodipine Global Levoamlodipine Revenue by Region: 2018-2029
3.3.1 Global Levoamlodipine Revenue by Region: 2018-2023
3.3.2 Global Levoamlodipine Revenue by Region: 2024-2029
3.4 North America Levoamlodipine Market Facts & Figures by Country
3.4.1 North America Levoamlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Levoamlodipine Sales by Country (2018-2029)
3.4.3 North America Levoamlodipine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Levoamlodipine Market Facts & Figures by Country
3.5.1 Europe Levoamlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Levoamlodipine Sales by Country (2018-2029)
3.5.3 Europe Levoamlodipine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Levoamlodipine Market Facts & Figures by Country
3.6.1 Asia Pacific Levoamlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Levoamlodipine Sales by Country (2018-2029)
3.6.3 Asia Pacific Levoamlodipine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Levoamlodipine Market Facts & Figures by Country
3.7.1 Latin America Levoamlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Levoamlodipine Sales by Country (2018-2029)
3.7.3 Latin America Levoamlodipine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Levoamlodipine Market Facts & Figures by Country
3.8.1 Middle East and Africa Levoamlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Levoamlodipine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Levoamlodipine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Levoamlodipine Sales by Type (2018-2029)
4.1.1 Global Levoamlodipine Sales by Type (2018-2023)
4.1.2 Global Levoamlodipine Sales by Type (2024-2029)
4.1.3 Global Levoamlodipine Sales Market Share by Type (2018-2029)
4.2 Global Levoamlodipine Revenue by Type (2018-2029)
4.2.1 Global Levoamlodipine Revenue by Type (2018-2023)
4.2.2 Global Levoamlodipine Revenue by Type (2024-2029)
4.2.3 Global Levoamlodipine Revenue Market Share by Type (2018-2029)
4.3 Global Levoamlodipine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Levoamlodipine Sales by Application (2018-2029)
5.1.1 Global Levoamlodipine Sales by Application (2018-2023)
5.1.2 Global Levoamlodipine Sales by Application (2024-2029)
5.1.3 Global Levoamlodipine Sales Market Share by Application (2018-2029)
5.2 Global Levoamlodipine Revenue by Application (2018-2029)
5.2.1 Global Levoamlodipine Revenue by Application (2018-2023)
5.2.2 Global Levoamlodipine Revenue by Application (2024-2029)
5.2.3 Global Levoamlodipine Revenue Market Share by Application (2018-2029)
5.3 Global Levoamlodipine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aristo Pharmaceuticals Pvt Ltd
6.1.1 Aristo Pharmaceuticals Pvt Ltd Corporation Information
6.1.2 Aristo Pharmaceuticals Pvt Ltd Description and Business Overview
6.1.3 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Product Portfolio
6.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Levoamlodipine Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Levoamlodipine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Lek
6.4.1 Lek Corporation Information
6.4.2 Lek Description and Business Overview
6.4.3 Lek Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lek Levoamlodipine Product Portfolio
6.4.5 Lek Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TEVA Levoamlodipine Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Macleods Pharmaceuticals
6.6.1 Macleods Pharmaceuticals Corporation Information
6.6.2 Macleods Pharmaceuticals Description and Business Overview
6.6.3 Macleods Pharmaceuticals Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Macleods Pharmaceuticals Levoamlodipine Product Portfolio
6.6.5 Macleods Pharmaceuticals Recent Developments/Updates
6.7 Caraco Pharmaceutical
6.6.1 Caraco Pharmaceutical Corporation Information
6.6.2 Caraco Pharmaceutical Description and Business Overview
6.6.3 Caraco Pharmaceutical Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Caraco Pharmaceutical Levoamlodipine Product Portfolio
6.7.5 Caraco Pharmaceutical Recent Developments/Updates
6.8 Sanis Health
6.8.1 Sanis Health Corporation Information
6.8.2 Sanis Health Description and Business Overview
6.8.3 Sanis Health Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanis Health Levoamlodipine Product Portfolio
6.8.5 Sanis Health Recent Developments/Updates
6.9 Jamp Pharma
6.9.1 Jamp Pharma Corporation Information
6.9.2 Jamp Pharma Description and Business Overview
6.9.3 Jamp Pharma Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jamp Pharma Levoamlodipine Product Portfolio
6.9.5 Jamp Pharma Recent Developments/Updates
6.10 Accel Pharma
6.10.1 Accel Pharma Corporation Information
6.10.2 Accel Pharma Description and Business Overview
6.10.3 Accel Pharma Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Accel Pharma Levoamlodipine Product Portfolio
6.10.5 Accel Pharma Recent Developments/Updates
6.11 Jubilant Generics
6.11.1 Jubilant Generics Corporation Information
6.11.2 Jubilant Generics Levoamlodipine Description and Business Overview
6.11.3 Jubilant Generics Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jubilant Generics Levoamlodipine Product Portfolio
6.11.5 Jubilant Generics Recent Developments/Updates
6.12 Angita Pharma
6.12.1 Angita Pharma Corporation Information
6.12.2 Angita Pharma Levoamlodipine Description and Business Overview
6.12.3 Angita Pharma Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Angita Pharma Levoamlodipine Product Portfolio
6.12.5 Angita Pharma Recent Developments/Updates
6.13 Florida DOH Central Pharmacy
6.13.1 Florida DOH Central Pharmacy Corporation Information
6.13.2 Florida DOH Central Pharmacy Levoamlodipine Description and Business Overview
6.13.3 Florida DOH Central Pharmacy Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Florida DOH Central Pharmacy Levoamlodipine Product Portfolio
6.13.5 Florida DOH Central Pharmacy Recent Developments/Updates
6.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
6.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Corporation Information
6.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Description and Business Overview
6.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Product Portfolio
6.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.15 Yangzijiang Pharmaceutical
6.15.1 Yangzijiang Pharmaceutical Corporation Information
6.15.2 Yangzijiang Pharmaceutical Levoamlodipine Description and Business Overview
6.15.3 Yangzijiang Pharmaceutical Levoamlodipine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yangzijiang Pharmaceutical Levoamlodipine Product Portfolio
6.15.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Levoamlodipine Industry Chain Analysis
7.2 Levoamlodipine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Levoamlodipine Production Mode & Process
7.4 Levoamlodipine Sales and Marketing
7.4.1 Levoamlodipine Sales Channels
7.4.2 Levoamlodipine Distributors
7.5 Levoamlodipine Customers
8 Levoamlodipine Market Dynamics
8.1 Levoamlodipine Industry Trends
8.2 Levoamlodipine Market Drivers
8.3 Levoamlodipine Market Challenges
8.4 Levoamlodipine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock